PuraPharm Corporation Limited (1498) Announces Board Composition and Committee Roles

Bulletin Express
10/31

PuraPharm Corporation Limited (1498) has issued an announcement dated 30 October 2025 detailing the composition of its Board of Directors, including executive, non-executive, and independent non-executive members.

The Board is led by Chairman and Executive Director, Mr. Chan Yu Ling, Abraham. Other Executive Directors include Ms. Man Yee Wai, Viola and Dr. Tsoi Kam Biu, Alvin. The non-executive directors are Mr. Leung Stephen Kwok Keung and Mr. Dong Zimeng, and the independent non-executive directors are Dr. Hung Ting On, John, Dr. Leung Lim Kin, Simon, and Prof. Tsui Lap Chee.

According to the announcement, the Audit Committee is chaired by Dr. Hung and includes Dr. Leung and Prof. Tsui. The Remuneration Committee is chaired by Dr. Leung and comprises Dr. Hung and Prof. Tsui. The Nomination Committee is chaired by Mr. Chan and includes Dr. Hung, Dr. Leung, Prof. Tsui, and Ms. Man.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10